Calibration methods used in cancer simulation models and suggested reporting guidelines
about
sameAs
Validation of population-based disease simulation models: a review of concepts and methodsValidation and calibration of structural models that combine information from multiple sources.Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers.Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population.Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKCurrent challenges in health economic modeling of cancer therapies: a research inquiry.Modeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India.An updated natural history model of cervical cancer: derivation of model parameters.The Preventable Risk Integrated ModEl and Its Use to Estimate the Health Impact of Public Health Policy Scenarios.Reporting guidelines for modelling studiesIdentifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach.The Brighton declaration: the value of non-communicable disease modelling in population health sciencesBayesian history matching of complex infectious disease models using emulation: a tutorial and a case study on HIV in Uganda.Do economic evaluations of targeted therapy provide support for decision makers?Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settingsEstimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.Validation and calibration of a computer simulation model of pediatric HIV infectionFitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementiaProjecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation modelObservation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.Quantifying demographic and socioeconomic transitions for computational epidemiology: an open-source modeling approach applied to India.Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer.Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityUsing Active Learning for Speeding up Calibration in Simulation Models.The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.A system dynamics model of clinical decision thresholds for the detection of developmental-behavioral disordersCost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancerModel performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases : a review and suggested reporting framework.Calibrating Parameters for Microsimulation Disease Models: A Review and Comparison of Different Goodness-of-Fit Criteria.Bayesian Methods for Calibrating Health Policy Models: A Tutorial.Economic evaluations with agent-based modelling: an introduction.An Overview of R in Health Decision Sciences.Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.Projecting Burden of Dementia in Spain, 2010-2050: Impact of Modifying Risk Factors.Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches.
P2860
Q28744274-43E249B0-8C2D-465A-AD77-11D70564BFD1Q30239838-1C072465-7EE0-4120-9B3C-6DA24AD754F7Q30579901-F3F4EDB0-B7FC-4B6F-8304-C9756149011EQ30979196-649C752D-91BC-4A83-A790-AB0111C800EBQ33648181-AF7B34A2-A32D-40D6-B288-3F44DFDB427DQ33723590-BF52048B-F6E6-4AD1-983B-60A32A234E1AQ33795154-5A374118-0ECC-4A15-9181-B6B0463D8C9EQ33805471-31DB5A00-4D41-4E38-A2FE-2AF626821C41Q33969384-0997BCEC-AEDC-42BB-AAFB-18743CEB7BFCQ34083083-25EAA777-CF69-49AE-91F8-C14595EEF2A0Q34330864-94F3943D-9B40-43DF-8C4D-859EE91227DFQ34470301-D138E1BC-0737-411C-98DF-0E455375085EQ34778132-64AAB9C9-83CE-4367-A0E3-54D42A8CF7DDQ34778413-277EA71E-2719-4E03-88FD-7DACC8F3154EQ34888575-339B9871-B306-461A-8056-CE98273046FFQ34974213-AABFEADC-279C-41D9-B53C-C746BACB48E7Q34978379-17030F77-F80A-4B88-AC05-C470A2FE84B5Q35050728-9F175727-9FE8-4E26-AF50-D1F5081CA177Q35070944-6FCA81AE-EF48-4D6B-B3EA-60D14D8ECB88Q35114370-34369F8C-DC38-44EF-9486-BB0FDE717B7AQ35167186-014137C0-B4C6-47ED-A8DD-5D85FCFAFD44Q35214109-058D76C9-B4C6-42D9-B892-45271D37044DQ35806400-4468F18F-4D93-49AD-BCD9-9436029C044FQ35906207-6ED8F8A8-E122-4E04-BD76-5B1C32FBAF19Q36286729-A6AD53C4-424D-4654-AF56-E08D14CCF4A4Q36615123-E8D8D7C1-BF22-4591-991A-F60F7E041524Q36803994-6938F1A5-1A03-4710-8C21-6AE9FC97531DQ37016576-9BABB738-DA94-44E3-AB08-11AE39D01AF8Q37228194-76795B2F-5CE0-4598-8140-13CFEFFDE248Q37440066-996B06E8-0D9E-44F8-ADE3-AFCBC4C144B2Q37651586-22F4C6AD-C29F-43BE-A855-BDC4B375961BQ38086133-90FC37C5-6AEE-4DBF-8575-7BE0562159AAQ38766423-203E5AA6-CA56-4259-8CC3-B965A85F8F13Q38936428-2DF92D06-AA15-4DAD-90F7-75E3138272CDQ39051954-986DF294-2D50-4BF4-8F9C-65B22F8DFC93Q39070617-4AA72F7E-03EC-4136-A891-68A3A3773EAFQ39249966-F46ED2C6-285E-4B40-9EE8-104F560264D4Q40400351-D2BD6FCD-6D95-4A93-B1D4-7F3D2019EF3EQ41324492-82E2D78C-8672-4BFF-A0EC-3807C8B09301Q46659871-EDD54A22-93DF-49F7-B244-D4B4582534CE
P2860
Calibration methods used in cancer simulation models and suggested reporting guidelines
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Calibration methods used in cancer simulation models and suggested reporting guidelines
@ast
Calibration methods used in cancer simulation models and suggested reporting guidelines
@en
Calibration methods used in cancer simulation models and suggested reporting guidelines
@nl
type
label
Calibration methods used in cancer simulation models and suggested reporting guidelines
@ast
Calibration methods used in cancer simulation models and suggested reporting guidelines
@en
Calibration methods used in cancer simulation models and suggested reporting guidelines
@nl
prefLabel
Calibration methods used in cancer simulation models and suggested reporting guidelines
@ast
Calibration methods used in cancer simulation models and suggested reporting guidelines
@en
Calibration methods used in cancer simulation models and suggested reporting guidelines
@nl
P2093
P2860
P3181
P1433
P1476
Calibration methods used in cancer simulation models and suggested reporting guidelines
@en
P2093
Amy B Knudsen
Chung Yin Kong
G Scott Gazelle
Natasha K Stout
P2860
P304
P3181
P356
10.2165/11314830-000000000-00000
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1035212179